Certara Acquires Applied Biomath Expanding Its Biosimulation Portfolio To Industrialize New Capabilities For Optimal Dosing For Novel Therapies
Acquiring Company
Certara
Acquired Company
Applied BioMath
RadnorConcordBiotechnologyPharmaceuticalConsultingBiotechnologyHealthcareDescription
Certara, Inc. (Nasdaq: CERT) today announced it has acquired Applied BioMath, an industry-leader in providing model-informed drug discovery and development support to help accelerate and de-risk therapeutic research and development (R&D). Together, Certara and Applied BioMath are the life sciences industry’s largest team of experts in quantitative systems pharmacology (QSP), a method of biosimulation used across the development lifecycle to predict endpoints, biomarkers and the most effective dosing regimen.
Quick answer
Certara is acquiring Applied BioMath, announced December 13, 2023. Certara is based in Radnor, Pennsylvania, United States.
- How much did Certara pay for Applied BioMath?
- The deal value was not disclosed.
- What does Certara do?
- Certara accelerates medicines using proprietary biosimulation software, technology, and services to transform traditional drug discovery and development.
- Where are Certara and Applied BioMath based?
- Certara is based in Radnor, Pennsylvania, United States. Applied BioMath is based in Concord, Massachusetts, United States.
- Who are the decision-makers at Certara?
- Fundz holds 1 contact at Certara. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Consulting
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Abbvie To Acquire Immunogen, Including Its Flagship Cancer Therapy Elahere® (Mirvetuximab Soravtansine-Gynx), Expanding Solid Tumor Portfolio (November 30, 2023)
- Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio (January 23, 2024)
- XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition (January 18, 2024)
- Lilly Completes Acquisition Of Point Biopharma (December 27, 2023)
- Abbvie To Acquire Cerevel Therapeutics In Transformative Transaction To Strengthen Neuroscience Pipeline (December 6, 2023)
- Versiti Acquires Indianapolis-Based Pearl Pathways (November 7, 2023)
Who to call at Certara, and when
When Certara changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Certara raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Certara, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Certara. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Certara makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Applied BioMath?
Applied BioMath was acquired by Certara, based in Radnor. The deal was reported on December 13, 2023. Certara accelerates medicines using proprietary biosimulation software, technology, and services to transform traditional drug discovery and development. Certara is publicly traded (CERT) and operates in Biotechnology.
When did Certara acquire Applied BioMath?
Certara's acquisition of Applied BioMath was reported on December 13, 2023. Certara, Inc. (Nasdaq: CERT) today announced it has acquired Applied BioMath, an industry-leader in providing model-informed drug discovery and development support to help accelerate and de-risk therapeutic research and development (R&D). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Applied BioMath do?
Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. It is privately held, operating in Biotechnology, and is based in Concord.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.